Foghorn Therapeutics Inc. SEC filings FHTX
Foghorn Therapeutics Inc. has 354 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (exit or restructuring costs, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Oct 1, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 21, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 4, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
May 1, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 24, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2024 | Dec 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 10, 2024 | Oct 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 22, 2024 | May 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2024 | May 20, 2024 |
| 8-K |
Current report
Other events
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 16, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 9, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 17, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Agreement ended
|
Aug 10, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Other events
|
Aug 8, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 28, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 5, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Other events
|
Apr 24, 2023 | Apr 24, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 9, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2022 | Oct 26, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 31, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 23, 2022 | Aug 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2022 | Aug 16, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2022 | May 19, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement
|
Apr 15, 2022 | Apr 15, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Agreement ended
|
Dec 21, 2021 | Dec 21, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 13, 2021 | Dec 10, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 1, 2021 | Aug 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 23, 2021 | Aug 23, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 14, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 9, 2021 | Jul 8, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 15, 2021 | Jun 14, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2021 | Apr 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 23, 2021 | Mar 21, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Results of operations
|
Dec 4, 2020 | Dec 4, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 25, 2020 | Nov 19, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 27, 2020 | Oct 27, 2020 |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FHTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1822462
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.